ID   TOR2_SCHPO              Reviewed;        2337 AA.
AC   Q9Y7K2; O94507;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2002, sequence version 2.
DT   07-APR-2021, entry version 157.
DE   RecName: Full=Serine/threonine-protein kinase tor2 {ECO:0000305|PubMed:11096119};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:22976295};
DE   AltName: Full=Phosphatidylinositol kinase homolog tor2;
DE   AltName: Full=Target of rapamycin kinase 2;
GN   Name=tor2 {ECO:0000303|PubMed:11096119};
GN   ORFNames=SPBC216.07c {ECO:0000312|PomBase:SPBC216.07c}, SPBC646.01c;
OS   Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Taphrinomycotina;
OC   Schizosaccharomycetes; Schizosaccharomycetales; Schizosaccharomycetaceae;
OC   Schizosaccharomyces.
OX   NCBI_TaxID=284812;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=972 / ATCC 24843;
RX   PubMed=11859360; DOI=10.1038/nature724;
RA   Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A.,
RA   Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S.,
RA   Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M., Collins M.,
RA   Connor R., Cronin A., Davis P., Feltwell T., Fraser A., Gentles S.,
RA   Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G., Holroyd S.,
RA   Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K., James K.D.,
RA   Jones L., Jones M., Leather S., McDonald S., McLean J., Mooney P.,
RA   Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C., Oliver K.,
RA   O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E., Rutherford K.M.,
RA   Rutter S., Saunders D., Seeger K., Sharp S., Skelton J., Simmonds M.N.,
RA   Squares R., Squares S., Stevens K., Taylor K., Taylor R.G., Tivey A.,
RA   Walsh S.V., Warren T., Whitehead S., Woodward J.R., Volckaert G., Aert R.,
RA   Robben J., Grymonprez B., Weltjens I., Vanstreels E., Rieger M.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Duesterhoeft A.,
RA   Fritzc C., Holzer E., Moestl D., Hilbert H., Borzym K., Langer I., Beck A.,
RA   Lehrach H., Reinhardt R., Pohl T.M., Eger P., Zimmermann W., Wedler H.,
RA   Wambutt R., Purnelle B., Goffeau A., Cadieu E., Dreano S., Gloux S.,
RA   Lelaure V., Mottier S., Galibert F., Aves S.J., Xiang Z., Hunt C.,
RA   Moore K., Hurst S.M., Lucas M., Rochet M., Gaillardin C., Tallada V.A.,
RA   Garzon A., Thode G., Daga R.R., Cruzado L., Jimenez J., Sanchez M.,
RA   del Rey F., Benito J., Dominguez A., Revuelta J.L., Moreno S.,
RA   Armstrong J., Forsburg S.L., Cerutti L., Lowe T., McCombie W.R.,
RA   Paulsen I., Potashkin J., Shpakovski G.V., Ussery D., Barrell B.G.,
RA   Nurse P.;
RT   "The genome sequence of Schizosaccharomyces pombe.";
RL   Nature 415:871-880(2002).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=11096119; DOI=10.1074/jbc.m010446200;
RA   Weisman R., Choder M.;
RT   "The fission yeast TOR homolog, tor1+, is required for the response to
RT   starvation and other stresses via a conserved serine.";
RL   J. Biol. Chem. 276:7027-7032(2001).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH RHB1.
RX   PubMed=17121544; DOI=10.1111/j.1365-2443.2006.01025.x;
RA   Uritani M., Hidaka H., Hotta Y., Ueno M., Ushimaru T., Toda T.;
RT   "Fission yeast Tor2 links nitrogen signals to cell proliferation and acts
RT   downstream of the Rheb GTPase.";
RL   Genes Cells 11:1367-1379(2006).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH MIP1; POP3; STE11 AND MEI2.
RX   PubMed=17046992; DOI=10.1242/jcs.03241;
RA   Alvarez B., Moreno S.;
RT   "Fission yeast Tor2 promotes cell growth and represses cell
RT   differentiation.";
RL   J. Cell Sci. 119:4475-4485(2006).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=16823372; DOI=10.1038/nbt1222;
RA   Matsuyama A., Arai R., Yashiroda Y., Shirai A., Kamata A., Sekido S.,
RA   Kobayashi Y., Hashimoto A., Hamamoto M., Hiraoka Y., Horinouchi S.,
RA   Yoshida M.;
RT   "ORFeome cloning and global analysis of protein localization in the fission
RT   yeast Schizosaccharomyces pombe.";
RL   Nat. Biotechnol. 24:841-847(2006).
RN   [6]
RP   IDENTIFICATION IN THE TORC1 COMPLEX, PHOSPHORYLATION AT SER-1539,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=18076573; DOI=10.1111/j.1365-2443.2007.01141.x;
RA   Hayashi T., Hatanaka M., Nagao K., Nakaseko Y., Kanoh J., Kokubu A.,
RA   Ebe M., Yanagida M.;
RT   "Rapamycin sensitivity of the Schizosaccharomyces pombe tor2 mutant and
RT   organization of two highly phosphorylated TOR complexes by specific and
RT   common subunits.";
RL   Genes Cells 12:1357-1370(2007).
RN   [7]
RP   FUNCTION.
RX   PubMed=17179073; DOI=10.1534/genetics.106.064170;
RA   Weisman R., Roitburg I., Schonbrun M., Harari R., Kupiec M.;
RT   "Opposite effects of tor1 and tor2 on nitrogen starvation responses in
RT   fission yeast.";
RL   Genetics 175:1153-1162(2007).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MIP1.
RX   PubMed=17261596; DOI=10.1128/mcb.01039-06;
RA   Matsuo T., Otsubo Y., Urano J., Tamanoi F., Yamamoto M.;
RT   "Loss of the TOR kinase Tor2 mimics nitrogen starvation and activates the
RT   sexual development pathway in fission yeast.";
RL   Mol. Cell. Biol. 27:3154-3164(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2238 AND SER-2240, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18257517; DOI=10.1021/pr7006335;
RA   Wilson-Grady J.T., Villen J., Gygi S.P.;
RT   "Phosphoproteome analysis of fission yeast.";
RL   J. Proteome Res. 7:1088-1097(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=20144990; DOI=10.1242/jcs.060319;
RA   Nakashima A., Sato T., Tamanoi F.;
RT   "Fission yeast TORC1 regulates phosphorylation of ribosomal S6 proteins in
RT   response to nutrients and its activity is inhibited by rapamycin.";
RL   J. Cell Sci. 123:777-786(2010).
RN   [11]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=22976295; DOI=10.1242/jcs.111146;
RA   Nakashima A., Otsubo Y., Yamashita A., Sato T., Yamamoto M., Tamanoi F.;
RT   "Psk1, an AGC kinase family member in fission yeast, is directly
RT   phosphorylated and controlled by TORC1 and functions as S6 kinase.";
RL   J. Cell Sci. 125:5840-5849(2012).
CC   -!- FUNCTION: Phosphatidylinositol 3-kinase homolog, component of TORC1,
CC       which regulates multiple cellular processes to control cell growth in
CC       response to environmental signals. TORC1 controls the switch between
CC       cell proliferation and differentiation by sensing nutrient
CC       availability. Nutrient limitation and environmental stress signals
CC       cause inactivation of TORC1. Active TORC1 positively controls cell
CC       growth and ribosome biogenesis by regulating ribosomal protein gene
CC       expression (PubMed:17121544, PubMed:17179073, PubMed:17261596). In
CC       nutrient rich conditions, responsible for the phosphorylation of AGC S6
CC       kinase (S6K) psk1 at 'Thr-392' and 'Thr-415', activating psk1 kinase
CC       activity and promoting phosphorylation of ribosomal protein S6. Also
CC       catalyzes the nutrient-dependent phosphorylation of sck1 and sck2
CC       (PubMed:20144990, PubMed:22976295). TORC1 negatively controls G1 cell-
CC       cycle arrest, sexual development and amino acid uptake. Represses
CC       mating, meiosis and sporulation efficiency by interfering with the
CC       functions of the transcription factor ste11 and the meiosis-promoting
CC       RNA-binding protein mei2 (PubMed:17046992).
CC       {ECO:0000269|PubMed:17046992, ECO:0000269|PubMed:17121544,
CC       ECO:0000269|PubMed:17179073, ECO:0000269|PubMed:17261596,
CC       ECO:0000269|PubMed:20144990, ECO:0000269|PubMed:22976295}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:22976295};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:22976295};
CC   -!- SUBUNIT: The target of rapamycin complex 1 (TORC1) is composed of at
CC       least mip1, pop3/wat1, tco89, toc1 and tor2 (PubMed:17046992,
CC       PubMed:18076573, PubMed:17261596). Tor2 interacts with the small GTPase
CC       rhb1 (PubMed:17121544). Tor2 interacts with ste11 and mei2
CC       (PubMed:17046992). {ECO:0000269|PubMed:17046992,
CC       ECO:0000269|PubMed:17121544, ECO:0000269|PubMed:17261596,
CC       ECO:0000269|PubMed:18076573}.
CC   -!- INTERACTION:
CC       Q9Y7K2; Q9P3W5: tel2; NbExp=3; IntAct=EBI-2014299, EBI-2014377;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16823372,
CC       ECO:0000269|PubMed:18076573}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CU329671; CAB40167.1; -; Genomic_DNA.
DR   PIR; T39913; T40577.
DR   RefSeq; NP_595359.2; NM_001021266.3.
DR   SMR; Q9Y7K2; -.
DR   BioGRID; 277243; 56.
DR   IntAct; Q9Y7K2; 7.
DR   STRING; 4896.SPBC216.07c.1; -.
DR   iPTMnet; Q9Y7K2; -.
DR   MaxQB; Q9Y7K2; -.
DR   PaxDb; Q9Y7K2; -.
DR   PRIDE; Q9Y7K2; -.
DR   EnsemblFungi; SPBC216.07c.1; SPBC216.07c.1:pep; SPBC216.07c.
DR   GeneID; 2540720; -.
DR   KEGG; spo:SPBC216.07c; -.
DR   PomBase; SPBC216.07c; tor2.
DR   VEuPathDB; FungiDB:SPBC216.07c; -.
DR   eggNOG; KOG0891; Eukaryota.
DR   HOGENOM; CLU_000178_7_1_1; -.
DR   InParanoid; Q9Y7K2; -.
DR   OMA; LNIQRYP; -.
DR   PhylomeDB; Q9Y7K2; -.
DR   BRENDA; 2.7.1.137; 5613.
DR   Reactome; R-SPO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-SPO-3371571; HSF1-dependent transactivation.
DR   Reactome; R-SPO-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-SPO-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-SPO-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-SPO-9639288; Amino acids regulate mTORC1.
DR   Reactome; R-SPO-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   PRO; PR:Q9Y7K2; -.
DR   Proteomes; UP000002485; Chromosome II.
DR   GO; GO:0000785; C:chromatin; IDA:PomBase.
DR   GO; GO:0005737; C:cytoplasm; IDA:PomBase.
DR   GO; GO:0005829; C:cytosol; HDA:PomBase.
DR   GO; GO:0005634; C:nucleus; IDA:CACAO.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:PomBase.
DR   GO; GO:0034064; C:Tor2-Mei2-Ste11 complex; IDA:PomBase.
DR   GO; GO:0031931; C:TORC1 complex; IDA:PomBase.
DR   GO; GO:0031932; C:TORC2 complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:PomBase.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:PomBase.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:InterPro.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0071851; P:mitotic G1 cell cycle arrest in response to nitrogen starvation; IMP:PomBase.
DR   GO; GO:0010507; P:negative regulation of autophagy; IMP:PomBase.
DR   GO; GO:0110045; P:negative regulation of cell cycle switching, mitotic to meiotic cell cycle; IMP:PomBase.
DR   GO; GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; IMP:PomBase.
DR   GO; GO:0010515; P:negative regulation of induction of conjugation with cellular fusion; IMP:PomBase.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; IBA:GO_Central.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:PomBase.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:PomBase.
DR   GO; GO:0007165; P:signal transduction; IGI:PomBase.
DR   GO; GO:0030435; P:sporulation resulting in formation of a cellular spore; IEA:UniProtKB-KW.
DR   GO; GO:0038202; P:TORC1 signaling; IDA:PomBase.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 1.20.120.150; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR024585; DUF3385_TOR.
DR   InterPro; IPR003152; FATC_dom.
DR   InterPro; IPR009076; FRB_dom.
DR   InterPro; IPR036738; FRB_sf.
DR   InterPro; IPR000357; HEAT.
DR   InterPro; IPR021133; HEAT_type_2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR003151; PIK-rel_kinase_FAT.
DR   InterPro; IPR014009; PIK_FAT.
DR   InterPro; IPR026683; TOR.
DR   PANTHER; PTHR11139:SF9; PTHR11139:SF9; 1.
DR   Pfam; PF11865; DUF3385; 1.
DR   Pfam; PF02259; FAT; 1.
DR   Pfam; PF02260; FATC; 1.
DR   Pfam; PF08771; FRB_dom; 1.
DR   Pfam; PF02985; HEAT; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   SMART; SM01346; DUF3385; 1.
DR   SMART; SM01343; FATC; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF47212; SSF47212; 1.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51189; FAT; 1.
DR   PROSITE; PS51190; FATC; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cytoplasm; Kinase; Meiosis; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Sporulation; Transferase.
FT   CHAIN           1..2337
FT                   /note="Serine/threonine-protein kinase tor2"
FT                   /id="PRO_0000088814"
FT   REPEAT          163..200
FT                   /note="HEAT 1"
FT   REPEAT          249..286
FT                   /note="HEAT 2"
FT   REPEAT          290..326
FT                   /note="HEAT 3"
FT   REPEAT          409..446
FT                   /note="HEAT 4"
FT   REPEAT          474..512
FT                   /note="HEAT 5"
FT   REPEAT          559..596
FT                   /note="HEAT 6"
FT   REPEAT          642..679
FT                   /note="HEAT 7"
FT   REPEAT          683..721
FT                   /note="HEAT 8"
FT   REPEAT          727..765
FT                   /note="HEAT 9"
FT   REPEAT          802..840
FT                   /note="HEAT 10"
FT   REPEAT          844..880
FT                   /note="HEAT 11"
FT   REPEAT          881..921
FT                   /note="HEAT 12"
FT   REPEAT          965..1004
FT                   /note="HEAT 13"
FT   REPEAT          1006..1043
FT                   /note="HEAT 14"
FT   DOMAIN          1228..1784
FT                   /note="FAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534"
FT   DOMAIN          1990..2304
FT                   /note="PI3K/PI4K"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   DOMAIN          2305..2337
FT                   /note="FATC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534,
FT                   ECO:0000255|PROSITE-ProRule:PRU00535"
FT   MOD_RES         1539
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18076573"
FT   MOD_RES         2238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18257517"
FT   MOD_RES         2240
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18257517"
SQ   SEQUENCE   2337 AA;  266379 MW;  190F448DA04FD2D9 CRC64;
     MKEFPGLKSR NEEIRNKAAN DLYEYVIAYS RELSGEALVQ FNNDVNKYVY TLIHSTDPLD
     RLAGVTAINR LIDYEGEDTT RITRFANYLR IILPGTDQKA TVLAAKALGR LAVPGGALTS
     EFVNFEVKRA LEWLQGERNE NRRYAAVLIL KELAKNTSTL IYAHIDSIFE LLWHGLRDPK
     VTIRIASADA LSEFLKIVRQ RDSSIRLQWY TSILNEAQRG VAQGSSDYIH GSLLVYRQLF
     LKAGMFMHER YREVSDIILQ FRDHKDLLIR KTVTELIATL AAYNPDEFVS NYLHVCMLHL
     LNLLKKENVK MLAFATIGKV AVAITNSIIP YLDPICDSIK ESLKIHIRNK SASDAAIFQC
     ISLLSIALGQ AFSNYAYDLF DLIFASGLSE ASYRALSDLA HNIPPLLPVI QERLLDMLSK
     ILSGRPFIPP GCPPQYVARS LKSSKSASLK TGFFPNDVYI LALKVLGNFD FSGYILNEFV
     KDCVVVYLEN NDPEVRKTAS ITCSQLFARD PILSQTSDHA IQVVAEVLEK LLTVGICDTV
     PDIRLTVLNS LDSRFNKHLA QADKIRLLFI AINDENFAVR ESALRIIGRL NVYNPAYVMP
     YLRKIMLKTL TILDYSTIIR TKEENAKLLC LLIAAAPRLI ESHVEPILQI LLPKAKDSSS
     IVAASIVNSL GEICQISGEV IVPFIKDLMP LIIEALQDQS SPIRRAAALK ALGNLSSSTG
     YVIDPYIEFP SLLDILIGIT KTEQDITIRR ETIKLIGTLG ALDPNRHRVL EKGTEKVVPE
     QKNIPPDISL LMSGIGPSSD EYYPTVVITA LMSILKDPSL TIHHTAVIQA VMYIFKTMGL
     RCAPFLSQII PEFIAVMRTC PTNILEFYFQ QLSILVLIVR QHIRSFLPDL FKLIKDFWNP
     HSNLQFTILS LIESLARAMQ GEFKPYLPSL LVMMLQIFDS DVSVDSVSTK KVLHAFIVFG
     DTLADYFHML LDPILRLYER NDVSIGIKES IMITIGRLSM VINLSEYASR IIHPVMRMLS
     CNNASLIRVS MDTVCALIYQ LNVDFAIFIP MIDKCLKMNG VTHETYSILV EQFLQEQPLP
     IKLNPYEKYD KPKLDVVASA ADITSKKLPV NQEILRNAWE ASQRSTKDDW QEWIRRLGVA
     LLRESPSHAL RACAALAAAY QPLARDLFNA SFVSCWSELY DHFQEELVKS IEIALTSPHI
     SPEIIQILLN LAEFMEHDDK PLPIDIRTLG AYAAKCHAFA KALHYKELEF IEEELVTKPS
     VDTIEALISI NNQLQQPDAA IGILKHAQQH DKMNLKETWY EKLQRWEDAL SAYEKREAAG
     AGNFEITMGK LRCLHALGEW DRLSQLAQEN WIHAGHDARR YIAPLSVAAA WGLGQWEQMD
     EYISVMKSES PDKAFFNAIV ALHRSQFEEA ASYITRARDL LDTELTALVG ESYNRAYSVA
     VRVQMLSELE EIITYKKAED KPEVREMIKK TWVRRLKGCQ RNVDVWQRML RIRSLVISPR
     DNMEMWIKFA NLCRKSGRIS LAKKSLNLLL EDDENLDNSL VLKKTHPSIV YANLKFLWAV
     DDKRKALNSM QEFTSQLISD INVDPALFVQ STSVNTQKSQ EEIQYYFHLL ARCYHKQGQW
     QQEIENNWSE GSFDGVLQSY MYATQFDSKW YKAWHSWALA NFEAVKFLEQ SEEQIPSAAY
     EQYIIPAVKG FFKSIALSKG NLQDTLRLLN LWFKFGNNSN VINTLNVGIS TVNIDIWLDV
     IPQLIARIHA SSLSVRKSVH QLLSDVGRAH PQALVYPLTV AAKSQSSARQ NAALAIMDSL
     KTHSPRLVEQ ARLVSHELIR AAILWHEQWH EGLEEASRLY FGDHNIEGMF AVLRPLHEML
     ERGPETLREI SFQQAFGRDL VEARDCCIRF EQTGDISDLN QAWDLYYQVF KKIRKQLPQL
     TTLDLQYVSP KLLHVHDLEL AVPGTYVSGK PVIRIVKFYP TFNVITSKQR PRRLSIKGSD
     GKDYQYVLKG HEDIRQDERV MQLFGLCNNL LLADPETFKR LLSIQRYPVI PLSPDSGLLG
     WVLDSDTLHV LIRDYRESRK ILLNIEHRLI IQMAPDYDRL TLLQKVEVFE YALLSTTGQD
     LYRVLWLKSR SSEAWLNRRT NYSRTLAVMS MVGYILGLGD RHPSNLMLDR YTGNIIHIDF
     GDCFEVAMHR EKFPEKIPFR LTRMLVNAME VSGIEGTFRI TCEHVMRVLR TNKESVMAVL
     EAFVYDPLIN WRLAPAYSPS IDEKQSNEPN TLLGETIDGL HRKRLNEEGI TLEERQKPEI
     LNQRAITVLN RVSNKLTGRD FKPQQQLDVP SQVEKLILQA TSIENLCLCY IGWCSFW
//
